Sector Chart Thiogenesis Therapeutics, Corp. OTC Markets
Stocks
TTIPF
CA88410L1022
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.4200 USD | -6.67% |
|
0.00% | -28.01% |
| 06-17 | Thiogenesis Therapeutics Appoints Gilad Aharon to its Board | MT |
| 06-17 | Thiogenesis Therapeutics, Corp. Appoints Gilad Aharon to Its Board of Directors | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 43.24B | |||||
| 35.25B | - | - | - | - | - |
| 30.22B | |||||
| 28.01B | |||||
| 24.08B |
Select your edition
All financial news and data tailored to specific country editions
